Analgesic effects of dexmedetomidine and remifentanil on periprocedural pain during percutaneous ablation of renal carcinoma.
Conclusions: This proof-of-concept study has shown that analgosedation during percutaneous ablation of renal carcinoma can be performed with a generally tolerable degree of patient satisfaction. However, pain occurs and should be managed adequately. Patient safety must be a major concern for the anaesthetic care.
PMID: 32067572 [PubMed - as supplied by publisher]
Source: Upsala Journal of Medical Sciences - Category: General Medicine Authors: Semenas E, Lönnemark M, Dahlman P, Hultström M, Eriksson M Tags: Ups J Med Sci Source Type: research
More News: Anesthesia | Anesthesiology | Cancer & Oncology | Carcinoma | General Medicine | Lidoderm | Morphine | Pain | Study